- Home
- TILE vs CERT Comparison
TILE vs CERT Comparison
Compare TILE & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TILE
- CERT
- Stock Information
- Founded
- TILE 1973
- CERT 2008
- Country
- TILE United States
- CERT United States
- Employees
- TILE N/A
- CERT N/A
- Industry
- TILE Home Furnishings
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- TILE Consumer Discretionary
- CERT Technology
- Exchange
- TILE Nasdaq
- CERT Nasdaq
- Market Cap
- TILE 1.6B
- CERT 1.9B
- IPO Year
- TILE N/A
- CERT 2020
- Fundamental
- Price
- TILE $25.87
- CERT $11.71
- Analyst Decision
- TILE Buy
- CERT Buy
- Analyst Count
- TILE 1
- CERT 8
- Target Price
- TILE $32.00
- CERT $15.57
- AVG Volume (30 Days)
- TILE 415.6K
- CERT 1.6M
- Earning Date
- TILE 10-31-2025
- CERT 11-06-2025
- Dividend Yield
- TILE 0.31%
- CERT N/A
- EPS Growth
- TILE 33.38
- CERT N/A
- EPS
- TILE 1.92
- CERT 0.05
- Revenue
- TILE $1,372,471,000.00
- CERT $405,755,000.00
- Revenue This Year
- TILE $7.40
- CERT $11.70
- Revenue Next Year
- TILE $4.74
- CERT $8.03
- P/E Ratio
- TILE $13.47
- CERT $237.24
- Revenue Growth
- TILE 5.11
- CERT 11.61
- 52 Week Low
- TILE $17.24
- CERT $8.64
- 52 Week High
- TILE $30.20
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- TILE 39.50
- CERT 45.29
- Support Level
- TILE $24.49
- CERT $11.31
- Resistance Level
- TILE $28.64
- CERT $12.94
- Average True Range (ATR)
- TILE 0.96
- CERT 0.53
- MACD
- TILE -0.23
- CERT -0.14
- Stochastic Oscillator
- TILE 33.25
- CERT 24.46
About TILE Interface Inc.
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.